Inventor · disambiguated record
Tamanna Lather
Also filed as: LATHER TAMANNA
12 granted patents·15 pending applications·8 citations·filing 2016–2025
84Inventor score
Files withPIKE THERAPEUTICS INC14STARTON THERAPEUTICS INC8PIKE THERAPEUTICS USA INC3AEQUUS PHARMACEUTICALS INC2
Top patents by PatentIndex Score
27 records- 0190US11197852B2Continuous delivery of lenalidomide and other immunomodulatory agentsSTARTON THERAPEUTICS INC·Filed 2020·Granted Dec 14, 2021·4 cites·18 claims
- 0284US12016829B2Pharmaceutical composition and method for treating seizure disordersPIKE THERAPEUTICS INC·Filed 2021·Granted Jun 25, 2024·1 cites·4 claims
- 0383US12121617B2Transdermal delivery of cannabidiolPIKE THERAPEUTICS INC·Filed 2021·Granted Oct 22, 2024·1 cites·21 claims
- 0482US12097293B2Transdermal delivery of cannabidiolPIKE THERAPEUTICS INC·Filed 2020·Granted Sep 24, 2024·1 cites·13 claims
- 0579US12383510B2Treatment of vomiting and nausea with minimum dose of olanzapineSTARTON THERAPEUTICS INC·Filed 2024·Granted Aug 12, 2025·0 cites·19 claims
- 0676US2025108043A1Continuous delivery of lenalidomide and other immunomodulatory agentsSTARTON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0775US12268699B2Transdermal delivery of tetrahydrocannabinolPIKE THERAPEUTICS INC·Filed 2024·Granted Apr 8, 2025·0 cites·21 claims
- 0873US2024261235A1Pharmaceutical Composition And Method For Treating Seizure DisordersPIKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0969US12201622B2Continuous delivery of lenalidomide and other immunomodulatory agentsSTARTON THERAPEUTICS INC·Filed 2021·Granted Jan 21, 2025·0 cites·18 claims
- 1069US10500196B2Transdermal and/or topical delivery systems composed of doxylamine succinate and pyridoxine hydrochloride in combination, or aloneAEQUUS PHARMACEUTICALS INC·Filed 2016·Granted Dec 10, 2019·1 cites·10 claims
- 1166US2025049821A1Pharmaceutical Composition and Method for Treating Seizure DisordersPIKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1265US2024299372A1Transdermal Drug Delivery Systems for Administration of a Therapeutically Effective Amount of Apixaban and Other Direct Oral AnticoagulantsPIKE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1364US11975112B2Treatment of vomiting and nausea with minimum dose of olanzapineSTARTON THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·11 claims
- 1462US2025248948A1Transdermal and/or Topical, Pharmaceutical Formulations Comprising Cannabidiol and/or Tetrahydrocannabinol for the Treatment of Chronic PainPIKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1562US2022000794A1Transdermal pharmaceutical formulations for the treatment of multiple sclerosisPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1661US2025312359A1Transdermal Delivery of TetrahydrocannabinolPIKE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1761US2021346310A1Transdermal and/or topical, pharmaceutical formulations comprising cannabidiol and/or tetrahydrocannabinol for the treatment of chronic painPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1857US12409132B2Transdermal delivery of dronabinolPIKE THERAPEUTICS USA INC·Filed 2021·Granted Sep 9, 2025·0 cites·4 claims
- 1957US2022347151A1Transdermal pharmaceutical formulations for the treatment of chronic painPIKE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2056US2021100737A1Transdermal delivery of dronabinolSTARTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2155US2022395468A1Transdermal Drug Delivery Systems for Administration of a Therapeutically Effective Amount of Lenalidomide and Other Immunomodulatory AgentsSTARTON THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2255US2022175718A1Transdermal pharmaceutical formulations for the treatment of cancerPIKE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2354US2024009204A1Treatment of Vomiting and Nausea with Minimum Dose of OlanzapineSTARTON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2454US2025381205A1Transdermal Delivery of DronabinolPIKE THERAPEUTICS USA INC·Filed 2025·Application pending·0 cites
- 2551US12186280B2Pharmaceutical composition and method for treating seizure disordersPIKE THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·0 cites·16 claims
- 2650US12409131B2Transdermal delivery of dronabinolPIKE THERAPEUTICS USA INC·Filed 2021·Granted Sep 9, 2025·0 cites·14 claims
- 2746US2018250281A1Transdermal delivery of doxylamine succinate and pyridoxine hydrochlorideAEQUUS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tamanna Lather files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →